Who is sponsoring NCT04943887?

NCT04943887 is sponsored by eSupport Health.

What drugs are being tested in NCT04943887?

Interventions in NCT04943887: eSupport Health Weekly Group Sessions for PwMS.

What condition does NCT04943887 study?

NCT04943887 studies Multiple Sclerosis.

Is NCT04943887 still recruiting?

NCT04943887 is currently completed. Last updated 23 August 2022.

Last reviewed 2022-08-23 · How we verify

NCT04943887: CONNECT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CONNECT Trial of eSupport Online Health-coach Moderated Support Groups for Multiple Sclerosis

Completed NA Last updated 23 August 2022

What this trial tests

NA trial testing eSupport Health Weekly Group Sessions for PwMS in Multiple Sclerosis in 52 participants. Completed in 1 June 2022.

Timeline

1 August 2021

Primary endpoint
1 June 2022

1 June 2022

Quick facts

Lead sponsor	eSupport Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	52
Start date	1 August 2021
Primary completion	1 June 2022
Estimated completion	1 June 2022
Sites	1 location across United States

Drugs / interventions tested

eSupport Health Weekly Group Sessions for PwMS

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

eSupport Health

Who can join

18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Within-subject waitlist-control group design trial of eSupport health-coach moderated online support group participation to address mental health needs in persons with multiple sclerosis (PwMS) from historically underrepresented groups (i.e., Black and Latinx patients).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04943887 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by eSupport Health
Last refreshed: 23 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04943887.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing